View Archive »
About The Cover
The cover for issue 30 of Oncotarget features Figure 2, "Synthesis scheme and diagram of cRGD-targeted nanoparticle following a double emulsion solvent evaporation method," from Malhotra, et al.
|
|
Table of Contents
Research Papers: Pathology
|
| Immunohistochemical analysis of RHAMM expression in normal and neoplastic human tissues: a cell cycle protein with distinctive expression in mitotic cells and testicular germ cells |
|
https://doi.org/10.18632/oncotarget.24939
|
| 20941-20952 |
Research Papers: Immunology
|
| DHX9 regulates production of hepatitis B virusderived circular RNA and viral protein levels |
|
https://doi.org/10.18632/oncotarget.25104
|
| 20953-20964 |
Research Papers
|
| 20Sprotopanaxadiol regioselectively targets androgen receptor: anticancer effects in castrationresistant prostate tumors |
|
https://doi.org/10.18632/oncotarget.24695
|
| 20965-20978 |
|
| Wnt5ainduced cell migration is associated with the aggressiveness of estrogen receptorpositive breast cancer |
|
https://doi.org/10.18632/oncotarget.24761
|
| 20979-20992 |
|
| Cancer cellselective clathrinmediated endocytosis of aptamer decorated nanoparticles |
|
https://doi.org/10.18632/oncotarget.24772
|
| 20993-21006 |
|
| Selective dissociation between LSD1 and GFI1B by a LSD1 inhibitor NCD38 induces the activation of ERG superenhancer in erythroleukemia cells |
|
https://doi.org/10.18632/oncotarget.24774
|
| 21007-21021 |
|
| Targeting the mevalonate pathway is a novel therapeutic approach to inhibit oncogenic FoxM1 transcription factor in human hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.24781
|
| 21022-21035 |
|
| Increasing aggressiveness of patientderived xenograft models of cervix carcinoma during serial transplantation |
|
https://doi.org/10.18632/oncotarget.24783
|
| 21036-21051 |
|
| Long noncoding RNAs are associated with metabolic and cellular processes in the jejunum mucosa of preweaning calves in response to different diets |
|
https://doi.org/10.18632/oncotarget.24898
|
| 21052-21069 |
|
| Histogram analysis parameters of dynamic contrastenhanced magnetic resonance imaging can predict histopathological findings including proliferation potential cellularity and nucleic areas in head and neck squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.24920
|
| 21070-21077 |
|
| Long term deficiency of vitamin D in germ cell testicular cancer survivors |
|
https://doi.org/10.18632/oncotarget.24925
|
| 21078-21085 |
|
| Establishment of preclinical chemotherapy models for gastroenteropancreatic neuroendocrine carcinoma |
|
https://doi.org/10.18632/oncotarget.24930
|
| 21086-21099 |
|
| Overexpressing TPTE2 TPIP a homolog of the human tumor suppressor gene PTEN rescues the abnormal phenotype of the PTEN–/– mutant |
|
https://doi.org/10.18632/oncotarget.24941
|
| 21100-21121 |
|
| Crossplatform comparison for the detection of RAS mutations in cfDNA ddPCR Biorad detection assay BEAMing assay and NGS strategy |
|
https://doi.org/10.18632/oncotarget.24950
|
| 21122-21131 |
|
| Clinical characteristics of nonsmall cell lung cancer harboring mutations in exon 20 of EGFR or HER2 |
|
https://doi.org/10.18632/oncotarget.24958
|
| 21132-21140 |
|
| Esophageal cancer cells resistant to TDM1 display alterations in cell adhesion and the prostaglandin pathway |
|
https://doi.org/10.18632/oncotarget.24975
|
| 21141-21155 |
|
| LpMab23recognizing cancertype podoplanin is a novel predictor for a poor prognosis of early stage tongue cancer |
|
https://doi.org/10.18632/oncotarget.24986
|
| 21156-21165 |
|
| Metabolic changes associated with metformin potentiates Bcl2 inhibitor Venetoclax and CDK9 inhibitor BAY1143572 and reduces viability of lymphoma cells |
|
https://doi.org/10.18632/oncotarget.24989
|
| 21166-21181 |
|
| MYC gene amplification is a rare event in atypical fibroxanthoma and pleomorphic dermal sarcoma |
|
https://doi.org/10.18632/oncotarget.24997
|
| 21182-21189 |
|
| Mean platelet volume as a predictive marker for venous thromboembolism in patients treated for Hodgkin lymphoma |
|
https://doi.org/10.18632/oncotarget.25002
|
| 21190-21200 |
|
| Comparison of coronary artery bypass grafting and percutaneous coronary intervention in patients with heart failure with reduced ejection fraction and multivessel coronary artery disease |
|
https://doi.org/10.18632/oncotarget.25006
|
| 21201-21210 |
|
| Chemopreventive activity of celastrol in drug–resistant human colon carcinoma cell cultures |
|
https://doi.org/10.18632/oncotarget.25014
|
| 21211-21223 |
|
| GSTM1 GSTT1 and GSTP1 polymorphisms and colorectal cancer risk in Polish nonsmokers |
|
https://doi.org/10.18632/oncotarget.25031
|
| 21224-21230 |
|
| BI2536 induces mitotic catastrophe and radiosensitization in human oral cancer cells |
|
https://doi.org/10.18632/oncotarget.25035
|
| 21231-21243 |
|
| Effects of CB2 and TRPV1 receptors’ stimulation in pediatric acute Tlymphoblastic leukemia |
|
https://doi.org/10.18632/oncotarget.25052
|
| 21244-21258 |
|
| Predicting hepatocellular carcinoma through crosstalk genes identified by risk pathways |
|
https://doi.org/10.18632/oncotarget.24915
|
| 21259-21267 |
|
| STAT3activated CD36 facilitates fatty acid uptake in chronic lymphocytic leukemia cells |
|
https://doi.org/10.18632/oncotarget.25066
|
| 21268-21280 |
|
| Prognostic value of the DNA integrity index in patients with malignant lung tumors |
|
https://doi.org/10.18632/oncotarget.25086
|
| 21281-21288 |
|
| CRM1/XPO1 expression in pancreatic adenocarcinoma correlates with survivin expression and the proliferative activity |
|
https://doi.org/10.18632/oncotarget.25088
|
| 21289-21295 |
|
| Could a plant derived protein potentiate the anticancer effects of a stem cell in brain cancer |
|
https://doi.org/10.18632/oncotarget.25090
|
| 21296-21312 |
|
| The effect of antiviral therapy on serum lipid profiles in chronic hepatitis C |
|
https://doi.org/10.18632/oncotarget.25092
|
| 21313-21321 |
|
| SMAR1 inhibits Wnt/βcatenin signaling and prevents colorectal cancer progression |
|
https://doi.org/10.18632/oncotarget.25093
|
| 21322-21336 |
|
| IgG4related kidney disease: the effects of a Rituximabbased immunosuppressive therapy |
|
https://doi.org/10.18632/oncotarget.25095
|
| 21337-21347 |
|
| Comparison of infectivity and spread between HSV1 and HSV2 based oncolytic viruses on tumor cells with different receptor expression profiles |
|
https://doi.org/10.18632/oncotarget.25096
|
| 21348-21358 |
|
| Multiinstitution analysis of racial disparity among AfricanAmerican men eligible for prostate cancer active surveillance |
|
https://doi.org/10.18632/oncotarget.25103
|
| 21359-21365 |
|
| Proteomic screening identifies the zonula occludens protein ZO1 as a new partner for ADAM12 in invadopodialike structures |
|
https://doi.org/10.18632/oncotarget.25106
|
| 21366-21382 |
|
| Signature program: a platform of basket trials |
|
https://doi.org/10.18632/oncotarget.25109
|
| 21383-21395 |
|
| Transformation of mouse T cells requires MYC and AKT activity in conjunction with inhibition of intrinsic apoptosis |
|
https://doi.org/10.18632/oncotarget.25113
|
| 21396-21410 |
|
| Deregulation of methylation of transcribedultra conserved regions in colorectal cancer and their value for detection of adenomas and adenocarcinomas |
|
https://doi.org/10.18632/oncotarget.25115
|
| 21411-21428 |
|
| MTBP inhibits the Erk1/2Elk1 signaling in hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.25117
|
| 21429-21443 |
|
| Functional significance of cooccurring mutations in PIK3CA and MAP3K1 in breast cancer |
|
https://doi.org/10.18632/oncotarget.25118
|
| 21444-21458 |
|
| Higher enterococcus counts indicate a lower risk of colorectal adenomas: a prospective cohort study |
|
https://doi.org/10.18632/oncotarget.25130
|
| 21459-21467 |
|
| Acquired resistance to everolimus in aromatase inhibitorresistant breast cancer |
|
https://doi.org/10.18632/oncotarget.25133
|
| 21468-21477 |
|
| Targeted nanoparticle delivery of therapeutic antisense microRNAs presensitizes glioblastoma cells to lower effective doses of temozolomide in vitro and in a mouse model |
|
https://doi.org/10.18632/oncotarget.25135
|
| 21478-21494 |
|
| A protein folding molecular imaging biosensor monitors the effects of drugs that restore mutant p53 structure and its downstream function in glioblastoma cells |
|
https://doi.org/10.18632/oncotarget.25138
|
| 21495-21511 |
|
| Antibodyassisted target identification reveals afatinib an EGFR covalent inhibitor downregulating ribonucleotide reductase |
|
https://doi.org/10.18632/oncotarget.25177
|
| 21512-21529 |
|
| Coffee consumption and risk of myocardial infarction: a doseresponse metaanalysis of observational studies |
|
https://doi.org/10.18632/oncotarget.23947
|
| 21530-21540 |
Clinical Research Papers
|
| The fallopian tube microbiome: implications for reproductive health |
|
https://doi.org/10.18632/oncotarget.25059
|
| 21541-21551 |
|
| Patients with high serum substance P levels previously to liver transplantation for hepatocellular carcinoma have higher risk of oneyear liver transplantation mortality |
|
https://doi.org/10.18632/oncotarget.25097
|
| 21552-21559 |
|
| Transarterial chemoembolization as a substitute to radiofrequency ablation for treating Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.25108
|
| 21560-21568 |
|
| A pilot study of peptide vaccines for VEGF receptor 1 and 2 in patients with recurrent/progressive high grade glioma |
|
https://doi.org/10.18632/oncotarget.25131
|
| 21569-21579 |
Reviews
|
| A myriad of roles of miR25 in health and disease |
|
https://doi.org/10.18632/oncotarget.24662
|
| 21580-21612 |
|
| Targeted therapies in the management of locally advanced and metastatic pancreatic cancer: a systematic review |
|
https://doi.org/10.18632/oncotarget.25085
|
| 21613-21627 |
Corrections
|
| Correction: Diagnostic and prognostic utilities of humoral fibulin3 in malignant pleural mesothelioma: Evidence from a metaanalysis |
|
https://doi.org/10.18632/oncotarget.25301
|
| 21628-21628 |
|
| Correction: Chidamide and decitabine can synergistically induce apoptosis of Hodgkin lymphoma cells by upregulating the expression of PU1 and KLF4 |
|
https://doi.org/10.18632/oncotarget.25302
|
| 21629-21629 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLC
